Mr. De La Parra-Solomon is an entrepreneur based in Tallinn, Estonia, that is focused on the Information Technology, Education, Health, International Trade, and Real Estate industry sectors. He is creative, results-driven, and has 18+ years of Digital Strategy experience in IT architecture, marketing, and IT implementation.
Mr. De La Parra-Solomon is the Chief Strategy Officer and Co-Founder of the Quantum Brain Research Institute (www.quantumbrain.institute), a HealthTech initiative established in Tallinn, Estonia focused on Mental Health and Information Technology solutions. He is also the Chief Executive Officer and Co-Founding Partner of Nutrily™ | Health & Wellness Builders, a dietary supplements, nutritional products, and sportswear European corporation established in Tallinn, Estonia.
Mr. De La Parra-Solomon serves as CEO and Co-founding Partner at The Solomon Brokerage Firm, an International Commodities Trading firm established in Tallinn, Estonia. He is also the CEO and Co-founding Partner of Solomon Real Estate, a renowned luxury real estate agency in Europe. He is also the Lead Digital Strategist of the VTBCommunity Foundation, a predictable finance-focused blockchain initiative in Gibraltar.
He is the former President & Co-founder of PetroM Renewable, and served as Vice President of Operations & Strategy at PetroM Corp across all of its divisions, including PetroM Logistics. Mr. De La Parra is the former CEO & Founder of Astrum Salud Móvil and its Telemedicine service Astrum Móvil, former Digital Strategy Director & Co-founder at Dr. Jois, BiorganicAging, What Skin Needs/WSN International Pty. Ltd. He also served as a member of the Board of Advisors and is former Chief Marketing Officer at ReAnima Advanced Biosciences and served as Digital Media Director at Bioquark, Inc. He also served as the Latin America Region Manager and Digital Strategy adviser at CardiacSense and is the former CITO & Senior Partner at Cerezo Editores.
Within the academic and educational fields, Mr. De La Parra-Solomon Member of the WAMS Executive Council (WAMS Executive Board), a Member of the WAMS Education & Training Board (ETB), a Member of the WAMS Editorial Board, a Member of the WAMS Coronavirus Safety Committee, an Honorary Member of the Academy Faculty FWAMS, WAMS Digital Strategy Chairman & a Fellow of the Academy. He is a WAMS Senior Partner, Executive Vice President: Executive Chairman of the WAMS Mobile Health Division, and the WAMS Chief Coordinating Officer of WAMS, The World Academy of Medical Sciences. He is also an Advisory Board member, functioned as the Chief Operating Officer, and is a Co-founding Partner at The Reprogramming Medicine Association. Mr. De La Parra-Solomon is also a member of Singularity University and of OpenExo.
In relation to the organizations that Mr. De La Parra-Solomon has collaborated with for social impact and empowerment, he is a member of the Laurentia Project and of Cerebro Mexico, he served as an Advisory Board member of the Lifeboat Foundation, as an Advisory Board member of the Future Worlds Center – Cyprus Neuroscience & Technology Institute (Senior TV Program). He is a voting citizen and is running for Mayor & future Parliamentary Candidate at Asgardia. He served as Chief Digital Strategy Officer and was a Member of the Board of Advisors at the Transdisciplinary Agora for Future Discussions, a member of the Web Committee at the Life Extension Advocacy Foundation/Lifespan.io, volunteered with SENS Research Foundation for the OncoSENS Program in Digital Strategy, and acted as Digital Strategy adviser at the Major Mouse Testing Program. He also functioned as the founder and former Board of Directors member of Astrum Fundación and was Digital Strategy Advisor for POKI Ciudad Orgánica. He is also a part of the General Member Board at the National Autism Association, the National Fibromyalgia Association, the International Literacy Association, and the United Spinal Association.
Mr. De La Parra-Solomon is also a member of several associations for technology including the World Blockchain Association, the Computing Technology Industry Association, the Internet Marketing Association, the Application Developers Alliance, and the Association of Strategic Marketing.
Mr. De La Parra-Solomon’s activities in arts & culture involve serving as Digital Strategy Advisor at Xicome Festival. He is a media professional at IMDB, SoundCloud, and ReverbNation and has had activities in the entertainment industry as a music producer, composer & arranger for Televisa with broadcast television, film, radio, and web, receiving international awards with aired content in more than 185 countries.
For the energy sector, he worked as the Vice President of Strategy & Operations of PetroM Energy and is also a member of the National Introducing Brokers Association and a part of the National Biodiesel Board (Alliance Program).
Ms. Susanna Uusmaa is a biomedical scientist with broad expertise in Medical Sciences and in International Business. Holding an MSBS degree, she is results-driven to integrate modern smart technologies into making substantive contributions to the biomedical sector.
Having conducted research in neuroscience and oncology and having proudly graduated from Tallinn University of Technology (TALTECH) and Tallinn University School of Natural Sciences and Health, Ms. Uusmaa takes an evidence-based approach to her professional objectives and also to her endeavors as a passionate healthy lifestyle entrepreneuse.
With a background in biomolecular and medical sciences, she has recently co-founded Quantum Brain Research Institute with the aim of supporting the development of neuroscientific research for neurocritical treatment applications through instructive programs in mental health assessment and management. She is also the Chief Science Officer and Co-Founding Partner of Nutrily™ | Health & Wellness Builders, a dietary supplements, nutritional products, and sportswear European corporation established in Tallinn, Estonia. Additionally, she is the CSO & Co-Founding Partner of RegenerAge®Elite Clinic.
In collaboration with the Luxembourg Institute of Health and Luxembourg Centre for Systems Biomedicine, she developed a complete standard operating procedure for differentiating and generating fully functional glial cells from induced pluripotent stem cells (iPSCs) in only 30 days.
Ms. Susanna Uusmaa is the Chairwoman of the WAMS National Council of Estonia, Member of the Academy Faculty, Fellow of the Academy, Member of the WAMS Education and Training Board (ETB), a Member of the WAMS Coronavirus Committee, and a Member of the WAMS Executive Council.
Moreover, she holds over 6 years of hard-working experience in business operations and relationship building in more than 5 countries around the globe, having created and nurtured mutually beneficial partnerships, enhanced workflow efficiency, and contributed to the growth of several initiatives with substantial savings.
Ms. Uusmaa’s biomedical undertakings have positioned her as an MSBS to be able to become an active contributor also to the longevity sector and put her expertise into helping people become their best version of themselves with properly validated and ethical practices.
Prof. Dr. M. Mark Karindas, MD, is a respected medical professional with a remarkable career dedicated to advancing the field of medicine. With over two decades of service, he holds the esteemed position of President and Founder at WAMS, The World Academy of Medical Sciences. Additionally, he serves as the distinguished Editor-in-Chief of the prestigious Journal of Oncobiomarkers, Associate Editor of the esteemed American Journal of Biomedicine, and is a valued member of the Editorial Board for the Journal of Cancer Sciences.
As a highly accomplished research scientist specializing in Clinical and Molecular Oncology, Dr. Karindas has made significant contributions to the field. He is renowned for his groundbreaking theories, including the Multicellular Origin of Cancer and “Oncogenetic Evolution,” as well as the OCAT and ECE theories. His pioneering work extends to the development of the Karindas Grading System (KGS), a comprehensive and universal paradigm for tumor grading, and a novel approach to clinical management in oncology.
Dr. Karindas’ research interests encompass a broad spectrum of critical areas within oncology, including oncogenesis, metastasis, cancer stem cells, tumor cell biology, molecular oncopathology, cell signaling, signal transduction, extracellular matrix, and the origin and evolution of cancer. Currently, he is diligently engaged in the creation and establishment of a revolutionary medical algorithmic system that will revolutionize the practice of oncology and have far-reaching implications across various medical disciplines.
Dr. Karindas’ unwavering dedication to advancing medical knowledge and improving patient care has positioned him as a prominent figure in the medical community. His groundbreaking research, visionary theories, and commitment to developing innovative approaches underscore his invaluable contributions to the field of medicine.
Dr. Katrin Uusmaa is a solid dental attention authority and an avid entrepreneur in the dental industry in the government and in the private sector. She is the CEO, Senior Dentist, and founder of Dr.Uusmaa.com in Tallinn, Estonia.
Boasting more than twenty years of expertise in her field of study, Dr. Uusmaa endeavors in ensuring top-quality service of dental care for an all-encompassing solution for patients looking to attend to their needs in Estonia. Her endeavors have coverage for the entire Baltic area as well as the Northern European region.
Dr. Katrin Uusmaa is dedicated to providing her patients with the most beautiful smile together with the best dental protection available nowadays. Check-ups are a major part of the job and are important for patients to keep on top of their oral care.
Dr. Uusmaa was granted the honor of acquiring her Dentistry diploma from the University of Tartu in 1991. In the course of her career as a stomatologist, centering on the structures, functions, and diseases of the mouth, she has had extensive experience in governmental and private sectors alike. Additionally, after finishing seven years of studies at the Dental Clinic Department of the Hospital Foundation at the University of Tartu, Dr. Katrin Uusmaa carried on with the completion of her 2-year Residency at the Tallinn Dental Clinic.
As a young doctor and during the newly independent Republic of Estonia at the beginning of ninety’s, Dr. Uusmaa put time and effort for two consecutive years into children’s dentistry services as a dedicated and committed orthodontist and stomatologist. Moreover, throughout 1994 and up until 1997, Dr. Katrin Uusmaa obtained additional experience in privately-held entities. In the year of 1998, she decided to establish her own private practice and incorporated it into what is now known as OÜ Katrin Uusmaa Hambaravi.
Under the Doctor’s Oath and Ethics commitment, Dr. Uusmaa’s aim truly is to preserve and promote public health, prevent diseases, treat the sick, and alleviate their suffering. She remains as one of the renowned dentists working without self-interest and acting accordingly to her work ethic in treating patients, willing to put work in abnormal hours, and attending to all medical emergencies with dedication and high moral standards.
As a result and since 2012, Dr. Katrin Uusmaa has focused on preserving and promoting a culture of health by partnering up with the Defence Forces of the Republic of Estonia, bringing solid dental solutions to the Health Centre of the military complex on an ongoing and distinguished collaboration.
In the course of seven years, Dr. Uusmaa treated a myriad of brave patients at the honorable Ämari Air Base, offering her dental services expertise and solemn dedication to the health of the Republic of Estonia Defence Forces with utmost pride and gratitude.
Dec 2008 - Present: CEO at DrUusmaa.com
Jan 2012 - Present: Republic of Estonia Defence Forces Health Centre
Jun 1994 - Jun 1997: Baltic Medical Partners
Jun 1985 - Jun 1991: University of Tartu – Dentistry
Jun 1980 - Jun 1982: Tallinn Health Care College, Dental Technician
Edward Cole is CEO of KATLAS Technology Limited, a leading Distributed Ledger Technology (DLT) firm in London. His journey began with a degree in Economics from the University of Leeds, laying the groundwork for his profound understanding of financial markets and economic trends.
Edward’s career has witnessed the transformation of financial markets from manual processes and paper-based systems to electronic trading and automated settlement. He navigated this evolution by negotiating licenses for new products with the London Stock Exchange, addressing the challenges of growing international markets and heightened regulatory scrutiny. During his tenure at Gerrard & National Ltd (1986-1993), Edward’s responsibilities spanned treasury cash management, stock operations, and settlements. An early adopter of Bloomberg, he recognized its value in market consensus for asset closing prices, facilitating informed risk management and boosting trading efficiency.
From here Edward joined the triple A-rated Union Bank Of Switzerland as a Director of Fixed Income Trading at UBS specializing in UK Inflation-Linked government bonds which later expanded into US & European as the markets developed.
In 2002, he accepted the role of Head of Global Inflation Sales at HSBC in London, to establish a centre of excellence, orchestrating the launch of the largest syndicated inflation issue at the time. As ambassador for this growing asset class, Edward introduced prominent global inflation managers to the organization, such as Pimco, Bridgewater, and BlueCrest.
Subsequently, Edward was invited to establish a new trading operation as the Head of Inflation at King & Shaxson Limited, an esteemed and longstanding organization in the City. Under his leadership, the company swiftly emerged as the UK market leader in inflation trading, achieving over 50% of the market turnover within two years, thanks to modern and reliable electronic matching and settlement systems.
At this time Edward co-founded Sciemus, now Occam Underwriters, serving as the Managing Director of Space Insurance. By utilising proprietary intelligence and risk modelling developed in collaboration with the MOD in Farnborough, satellite operators, such as Immarsat, were empowered to self-insure their portfolios with special purpose vehicles, delivering dramatic reductions in insurance premiums and changing the industry.
In 2019, driven by an entrepreneurial vision, Edward established KATLAS Technology Limited with a focus on enhancing data management in healthcare and supply chains. The initial product, MaiHealth, aimed to showcase responsible AI integration across the patient pathway, prioritizing personalized treatment while ensuring the utmost confidentiality of sensitive data. As the CEO, Edward Cole continues to lead KATLAS Technology, utilizing his extensive background in finance and technology to pioneer innovations in Distributed Ledger Technology, governance, and automated trading platforms. His journey reflects visionary leadership and a steadfast commitment to excellence in the dynamic intersection of finance and technology.